Immy Inc.
rapid fungal diagnostic tests and assays
- Sector
- Medtech
- Headquarters
- TROY, MI
- Latest Form D
- $536K, Dec 2020
- Total capital
- $6.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $6.1M
- 21 Form D · last Dec 2020
- 70 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 4 pending · first 2015
- Rank in peer group#31 of 160
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 21st filing$536K
- Private capital raisedForm D · SEC · 20th filing$381K
- Private capital raisedForm D · SEC · 19th filing$50K
- Private capital raisedForm D · SEC · 18th filing$75K
- Private capital raisedForm D · SEC · 17th filing$21K
- Private capital raisedForm D · SEC · 16th filing$476K
- Offering registeredForm D · SEC · 15th filing$1.8M
- Private capital raisedForm D · SEC · 14th filing$25K
- Private capital raisedForm D · SEC · 13th filing$39K
- Private capital raisedForm D · SEC · 12th filing$277K
- Private capital raisedForm D · SEC · 11th filing$63K
- Private capital raisedForm D · SEC · 10th filing$550K
- Private capital raisedForm D · SEC · 9th filing$350K
- Private capital raisedForm D · SEC · 8th filing$70K
- Private capital raisedForm D · SEC · 7th filing$400K
- Private capital raisedForm D · SEC · 6th filing$250K
- Private capital raisedForm D · SEC · 5th filing$790K
- Private capital raisedForm D · SEC · 4th filing$294K
- Private capital raisedForm D · SEC · 3rd filing$377K
- Private capital raisedForm D · SEC · 2nd filing$252K
- Private capital raisedForm D · SEC · 1st filing$812K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 160 peers
Line = medianMedtech · Instrument
- Granted patents#31 · top 19%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Arinder G. MahalExecutive OfficerNamed in SEC Form D filings
- Clarence G. ChandranDirectorNamed in SEC Form D filings
- Clrence G. ChandranDirectorNamed in SEC Form D filings
- David G. DandurandExecutive OfficerNamed in SEC Form D filings
- Douglas Peter MagyariExecutive Officer, DirectorNamed in SEC Form D filings
- John C. AdamsDirectorNamed in SEC Form D filings
Show all 14 people
- John Arthur MarxerExecutive Officer, DirectorNamed in SEC Form D filings
- Laureen Sue MagyariExecutive OfficerNamed in SEC Form D filings
- Mark TytherleighExecutive Officer, DirectorNamed in SEC Form D filings
- Mary Ann WehrExecutive OfficerNamed in SEC Form D filings
- Robert G. LiggettExecutive Officer, DirectorNamed in SEC Form D filings
- Robert G. Liggett, Jr.Executive Officer, DirectorNamed in SEC Form D filings
- Salvatore Peter VilardiExecutive Officer, DirectorNamed in SEC Form D filings
- Vyomesh G. JoshiDirectorNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 8- GrantedHead Mounted Display Assembly With Structural Frame And Separate Outer FrameUSPTOUS 11,187,908
- GrantedHead Mounted Display With Non-pupil Forming Optical PathUSPTOUS 10,078,223
- GrantedHead Mounted Display With Micro-display Alignment MechanismUSPTOUS 9,268,139
Show all 8 patent records
- Head Mounted Display Assembly With Structural Frame And Separate Outer FrameNov 30, 2021 · US 11,187,908Granted
- Head Mounted Display With Non-pupil Forming Optical PathSep 18, 2018 · US 10,078,223Granted
- Head Mounted Display With Micro-display Alignment MechanismFeb 23, 2016 · US 9,268,139Granted
- Head Mounted Display Having Alignment Maintained Via Structural FrameOct 6, 2015 · US 9,151,954Granted
- Head Mounted Display With Micro-display Alignment MechanismApplication PCTUS2014029719Pending
- Head Mounted Display Having Alignment Maintained Via Structural FrameApplication PCTUS2014029714Pending
- Head Mounted Display AssemblyApplication PCTUS2014029708Pending
- Head Mounted Display With Non-pupil Forming Optical PathApplication PCTUS2014029725Pending
Related companies, and why
- EMRI SYSTEMS LLPSimilar federal contract value in Medtech · null in contracts
- BIOMERICA INCSimilar federal contract value in Medtech · null in contracts
- BRUKER CORPSimilar federal contract value in Medtech · null in contracts
- Minimally Invasive Spinal Technology, LLCSimilar federal contract value in Medtech · null in contracts
- TriAgenics, IncSimilar federal contract value in Medtech · null in contracts
- 3Spine, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .